Get your free ETF data sample from our comprehensive offerings. Start your free trial→
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
MEDX ETF · Horizon Kinetics Medical ETF
The MEDX Exchange Traded Fund (ETF) is provided by Horizon Kinetics LLC. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 1:30 PM UTC
LIVE
CLOSED
This fund is part ofTomorrow's Treatments1M perf.-1.75%
Last price
$33.20
1M perf.
-4.47%
1M flows
N/A
AuM
€16M
E/R
0.85%
Rating
Not rated
ESG Consensus®
MEDX
$33.20
Performance & flows
Segment for quartile rank
December 15, 2025 → March 13, 2026
Create a free account to view the flows graph
MEDX
$33.19
-0.59%
Tomorrow's Treatments
+0.53%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -4.47%  | -0.59%  | +20.00% | +25.75% | N/A | -6.45% | -0.17% | -0.17% | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
More details
NAV
3/13/2026
$33.19
1D NAV change
-0.70%
Dividend policy
No. of holdings
29
Inception date
1/27/2023
Jurisdiction
United States
Distribution
United States
Legal structure
Open-end Investment Company
Base currency
USD
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
Horizon Kinetics Medical ETF (the “Fund”) seeks to provide long-term growth of capital
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSimilar ETFs in your region
HRTS
1M perf.
-5.84%
E/R
0.99%
IHE
1M perf.
-4.25%
E/R
0.38%
UMDV
1M perf.
-6.21%
E/R
0.25%
VHT
1M perf.
-4.77%
E/R
0.09%
BMED
1M perf.
-6.03%
E/R
0.77%
Advertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -0.59% | +20.00% | +25.75% | N/A |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
USA
84.84%
Ireland
3.93%
Switzerland
2.85%
Unavailable
8.38%
Sectors
Health Care
74.67%
Unavailable
25.33%
Diversification
Total weight of top 15 holdings out of 29
Top 15 holdings
Data as of January 31, 2026
LILLY
ABBVIE
US66987V1098
JOHNSON&JOHNSON
US0463531089
IONIS PHARMACEUTICALS INC
BRISTOL-MYERS SQUIBB
ALNYLAM PHARMACEUTICALS
Create a free account to view top holdings
AMGEN-T
ALKERMES
MERCK & CO INC
PFIZER
CRISPR THERAPEUTICS
US37733W2044
BIOGEN INC
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Horizon Kinetics LLC
Horizon Kinetics LLC ID Card
Number of funds
9
Total AuM
€1.41B
Expense ratio range
0.52% - 0.85%
Average expense ratio
0.8133%
Top 5 funds by Horizon Kinetics LLC
Frequently asked questions about MEDX
What does Horizon Kinetics Medical ETF, MEDX, invest in?
MEDX is a Active ETF. This ETF provides exposure to Other Equities.
What is the Total Expense ratio (TER) of MEDX?
MEDX carries a total expense ratio (TER) of 0.85%, indicating the annual cost for holding the fund.
When was MEDX launched?
MEDX was introduced to the market on January 27, 2023. It trades on United States
Who is the ETF issuer of MEDX?
Horizon Kinetics Medical ETF, MEDX, is provided by Horizon Kinetics LLC. Learn more about Horizon Kinetics LLC here.
What is the current assets under management (AUM) of MEDX?
MEDX oversees €16M in assets as of March 13, 2026.
How has MEDX performed lately?
Based on data from March 13, 2026, MEDX returned -4.47% over the past month, -0.59% over the last three months and -0.17% year-to-date.
Does MEDX distribute dividends?
MEDX follows a distributing dividend policy, meaning it pays out income to investors. As of March 13, 2026, its 12-month trailing yield was 1.23%.
What are the main country or region exposures of MEDX?
As of January 31, 2026, MEDX has significant geographic allocations in USA, Ireland and Switzerland.
In which sector or theme does MEDX invest in?
As of January 31, 2026, MEDX focuses largely on Health Care.
How many securities does MEDX hold and how diversified is it?
As of January 31, 2026, MEDX holds 29 positions in its portfolio, with 81.25% of assets concentrated in its top 15 holdings.
What are the main positions in MEDX?
As of January 31, 2026, MEDX top three holdings include LILLY, ABBVIE and US66987V1098.
What is the base currency of MEDX?
The base currency of MEDX is USD.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
